could glp-1 be the next mental health drug GLP-1s may improve some outcomes in addition to lowering body weight Could GLP-1 drugs have mental

The kidney and cardiovascular outcome trials

Market Statistics Key Takeaways By type of GLP-1 agonist drugs, the long-acting GLP-1 agonist segment dominated in 2025

This means they are more expensive and therefore not as widely available in some countries, such as those with public health care systems compared to insurance-funded healthcare provision

For individuals with BMI above 40 or 50, the difference between 20% and 28% weight loss can be the difference between still being classified as obese and reaching a healthy weight range

You take it orally, and the timing matters

Retrieved July 10th, 2024 from Novo Nordisk (n.d.)